Free Trial

eFFECTOR Therapeutics (EFTRW) Short Interest Ratio & Short Volume

eFFECTOR Therapeutics logo

eFFECTOR Therapeutics Short Interest Data

eFFECTOR Therapeutics (EFTRW) has a short interest of 20,700 shares. This marks a 12.50% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.5, indicating that it would take 0.5 days of the average trading volume of 38,718 shares to cover all short positions.

Current Short Interest
20,700 shares
Previous Short Interest
18,400 shares
Change Vs. Previous Month
+12.50%
Dollar Volume Sold Short
$24.84
Short Interest Ratio
0.5 Days to Cover
Last Record Date
June 30, 2024
Today's Trading Volume
0 shares
Average Trading Volume
38,718 shares
Today's Volume Vs. Average
0%
Short Selling eFFECTOR Therapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for eFFECTOR Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

EFTRW Short Interest Over Time

EFTRW Days to Cover Over Time

EFTRW Percentage of Float Shorted Over Time

eFFECTOR Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/30/202420,700 shares $24.84 +12.5%N/A0.5 $0.00
6/15/202418,400 shares $717.60 -0.5%N/A0.4 $0.04
5/31/202418,500 shares $728.90 +2.8%N/A0.8 $0.04
5/15/202418,000 shares $369.00 -3.2%N/A0.6 $0.02
4/30/202418,600 shares $522.66 +73.8%N/A0.6 $0.03
4/15/202410,700 shares $373.43 +148.8%N/A0.3 $0.03
3/31/20244,300 shares $580.93 +53.6%N/A0.1 $0.14
3/15/20242,800 shares $365.60 -3.5%N/A0.1 $0.13
2/29/20242,900 shares $433.55 -31.0%N/A0.2 $0.15
2/15/20244,200 shares $449.40 +121.1%N/A0.4 $0.11
1/31/20241,900 shares $143.83 -9.5%N/A0.3 $0.08
1/15/20242,100 shares $228.90 -34.4%N/A0.5 $0.11
12/31/20233,200 shares $472.00 +220.0%N/A2.2 $0.15
12/15/20231,000 shares $123.10 -75.0%N/A0.9 $0.12
11/30/20234,000 shares $587.60 -11.1%N/A1.4 $0.15
11/15/20234,500 shares $619.65 -10.0%N/A1.6 $0.14
10/31/20235,000 shares $700.00 +51.5%N/A1.4 $0.14
10/15/20233,300 shares $462.00 -17.5%N/A0.8 $0.14
9/30/20234,000 shares $304.00 -9.1%N/A0.8 $0.08
9/15/20234,400 shares $426.80 -62.1%N/A0.9 $0.10
8/31/202311,600 shares $2,088.00 -0.9%N/A2.6 $0.18
8/15/202311,700 shares $1,755.00 -16.4%N/A1.9 $0.15
7/31/202314,000 shares $2,100.00 -14.1%N/A2.4 $0.15
7/15/202316,300 shares $2,502.05 -15.5%N/A3.1 $0.15
6/30/202319,300 shares $3,348.55 -15.0%N/A4.2 $0.17
6/15/202322,700 shares $4,540.00 -47.2%N/A4.9 $0.20
5/31/202343,000 shares $7,310.00 +13.5%N/A9.8 $0.17
5/15/202337,900 shares $6,443.00 -0.3%N/A4.9 $0.17
4/30/202338,000 shares $5,320.00 -0.3%N/A4.2 $0.14
4/15/202338,100 shares $5,600.66 -0.3%N/A4.2 $0.15
3/31/202338,200 shares $4,935.44 -3.8%N/A4 $0.13
3/15/202339,700 shares $6,153.50 +415.6%N/A4.1 $0.16
2/28/20237,700 shares $843.15 -16.3%N/A0.8 $0.11
2/15/20239,200 shares $1,334.00 -51.6%N/A1.3 $0.15
1/31/202319,000 shares $2,654.30 -11.6%N/A3.1 $0.14
1/15/202321,500 shares $3,418.50 +6.4%N/A1.5 $0.16
12/30/202220,200 shares $3,306.74 -24.6%N/A1.4 $0.16
12/15/202226,800 shares $2,948.00 -23.9%N/A1.7 $0.11
11/30/202235,200 shares $4,118.40 -6.4%N/A2.1 $0.12
11/15/202237,600 shares $5,264.00 -20.3%N/A1.6 $0.14
We recommended Palantir in 2021, now we’re recommending this... (Ad)

My research indicates there is only one investment that can meet AI's unprecedented demand for energy.

Click to get the name and ticker symbol
10/31/202247,200 shares $4,720.00 -12.6%N/A1.3 $0.10
10/15/202254,000 shares $7,959.60 -3.1%N/A2 $0.15
9/30/202255,700 shares $11,329.38 -19.6%N/A2.1 $0.20
9/15/202269,300 shares $13,860.00 +919.1%N/A2.8 $0.20
8/31/20226,800 shares $884.00 -39.3%N/A0.3 $0.13
8/15/202211,200 shares $996.80 -13.9%N/A0.6 $0.09
7/31/202213,000 shares $1,690.00 -5.8%N/A2.1 $0.13
7/15/202213,800 shares $2,760.00 No ChangeN/A3.5 $0.20

EFTRW Short Interest - Frequently Asked Questions

What is eFFECTOR Therapeutics' current short interest?

Short interest is the volume of eFFECTOR Therapeutics shares that have been sold short but have not yet been covered or closed out. As of June 30th, traders have sold 20,700 shares of EFTRW short. Learn More on eFFECTOR Therapeutics' current short interest.

Is eFFECTOR Therapeutics' short interest increasing or decreasing?

eFFECTOR Therapeutics saw a increase in short interest in June. As of June 30th, there was short interest totaling 20,700 shares, an increase of 12.5% from the previous total of 18,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($3.71 billion), TC Energy Co. ($2.95 billion), Moderna, Inc. ($2.63 billion), Royal Caribbean Cruises Ltd. ($2.53 billion), Paychex, Inc. ($2.03 billion), Cencora, Inc. ($2.03 billion), Tractor Supply ($1.91 billion), Rivian Automotive, Inc. ($1.78 billion), Chesapeake Energy Co. ($1.50 billion), and United Therapeutics Co. ($1.40 billion). View all of the most shorted stocks.

What does it mean to sell short eFFECTOR Therapeutics stock?

Short selling EFTRW is an investing strategy that aims to generate trading profit from eFFECTOR Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against eFFECTOR Therapeutics?

A short squeeze for eFFECTOR Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of EFTRW, which in turn drives the price of the stock up even further.

How often is eFFECTOR Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EFTRW, twice per month. The most recent reporting period available is June, 30 2024.




This page (NASDAQ:EFTRW) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners